This hands-on programme will help you develop the key skills needed to navigate the ever-changing (bio) pharmaceutical environment. Aimed at management, leaders of projects and professionals seeking to advance their career the course will provide you with the platform to grow and develop. Over 5-days you will focus on 5 key areas including pharma strategy, change management, financial, marketing and relationship management.
Our expert faculty have unrivalled experience and expertise across the pharmaceutical industry, providing invaluable knowledge gained from working with the world’s most prestigious international corporations. Through them, you will explore real-life examples pharma management face in today’s challenging market and embark on a continuous case study, designed to apply and cement the skills and techniques taught on the course.
Over 5 days they will share their consulting and business experience, providing a range of dynamic frameworks and tools for you to use in your role. Modules covered include:
Throughout the 5 days of the course you will follow a case study based on a realistic model of a Pharmaceutical company, mapping out its strategic direction, making key decisions and ultimately endeavouring to ensure the commercial success of the business. The case study provides you with the platform to apply the skills and techniques learned each day.
As a delegate of the Pharma & Biopharm Mini-MBA delegates you will be enrolled onto our VLE where you will get access to materials to support your preparation pre-event and revision of concepts post-event.
Through this platform you will be able to access pre-reading materials, trainer videos and an interactive forum for you to engage with the trainer and your peers.
Day 1: Change Management
Roger Holdsworth has over 20 years’ experience in senior management in the biopharmaceutical industry, starting in R&D project management and moving on to alliance and portfolio management. Over this period, he has been involved in a broad range of development activities both from the R&D and commercial point of view.
For the past ten years, he has held senior posts in portfolio management, beginning with the setup of the portfolio analysis and management system in Celltech. His role continued following the acquisition of Celltech by the Belgian Pharmaceutical company UCB in 2004. From that time until the end of 2010, he was Director of R&D Portfolio Management. He carried out the evaluation of a broad portfolio of chemical and biological entities in the CNS and Immunology therapeutic areas. Roger provided decision support relating to late phase development to the most senior management groups within the company.
Following his retirement from UCB, he has maintained an active interest in the industry and its progress.
Before moving into portfolio management, he was a senior project leader at Celltech organisation where he led a number of development alliances with international pharmaceutical companies.
Day 2: Strategy
Dr Laura Brown
Laura is Chairman of an International Pharmaceutical Management Consultancy, Course Director and Lecturer for the MSc in Clinical Research at the University of Cardiff, and is also Course Director for the MSc in Regulatory Affairs, TOPRA and University of Hertfordshire. Laura developed the first Pharma mini-MBA course almost 20 years ago. She has also worked as an Associate with Cranfield School of Management on several courses including the Leadership module of the MBA programme and Strategic Thinking courses.
Laura has extensive experience in senior management roles in the pharmaceutical industry and has worked for several pharmaceutical companies including GSK, Hoeschst Marion Roussell and Phoenix International and consulted internationally with numerous pharmaceutical companies in the EU, US, Singapore, China and India.
Day 3: Marketing
Jan Flynn, BSc MBA
Jan is currently the Marketing Manager for Rosemont Pharmaceuticals Ltd. She has worked in the pharmaceutical industry for over 20 years for companies including Glaxo SmithKline, Schering-Plough, LIG, Knoll and running her own consultancy. She has worked in toxicology, regulatory affairs, sales, international marketing, medical copywriting and advertising. This has given her a wide background of experience and during her career she worked on most drug categories as well as many medical devices.
Jan has a degree in Biochemistry and Toxicology, an MBA, and is a Fellow of the Royal Society of Medicine.
Day 4: Finance
Andre Lanser ACA
Andre is a consulting trainer as well as a corporate finance practitioner. He has delivered courses for banks around the world in the areas of Credit, Corporate Finance, Valuation and Financial Modelling.
Andre qualified as a Chartered Accountant, completing articles with PricewaterhouseCoopers. He started his career with a subsidiary of Commercial Union, involved in the steel manufacturing industry. His experience ranged from systems implementation, credit assessment of the highly risky construction industry customers, heading up the finance functions to successfully turning the business around and then selling the company through a trade sale. He later joined Commercial Union in the investment back-office function, reengineering the investment back office and later headed-up a team who implemented a new investment management system for both the back office and the front office.
His career then spanned over 12 years in the Venture Capital and Private Equity arena, where he has gained a vast amount of experience in the corporate analysis and valuation field.
He is a specialist in developing and training finance related courses, including corporate credit related topics, credit analysis and cash flow analysis with a special focus on the banking sector, derivatives, and financial modelling courses. His training experience spans a period of more than 15 years.
Day 5: Relationships
John began his career as a scientist in the Wellcome Foundation (now GSK). He moved after some years to a new career in training/HR, first as a trainer and eventually as a Learning and Development Business Partner. He left to become a consultant in the 1990's, working as a freelancer running team building sessions, personal skills courses and doing instructional design and coordination.
In 2001 he co-founded PPLMD Ltd, which specialises in enhancing collaborative working in the Pharma, Biotech and related service industries. John and his partner have created an educational program, 'Molecules to Markets', that helps companies to build knowledge of how the pharma business operates. They also provide project management consulting, team/leader coaching and training, particularly for the Biotech sector. In addition, they help pharma companies to manage alliances more effectively. John has developed several innovative measurement tools including a ‘relationship health’ questionnaire and a 'culture match' questionnaire. PPLMD Ltd are the preferred suppliers to the London-Cambridge based cluster One Nucleus, and are on the Exec committee of the PIPMG (Pharmaceutical Industry Project Management Group). John is also a founder member of ‘The Collaboration Project’ – a network for project, outsourcing and alliance managers.
This interactive programme is ideal for:
All PTI courses are CPD certified.
The practical exercises made you think and helped to consolidate knowledge.
I chose this course to get a broader view on business operations beyond my daily R&D activities. Enjoyed team work and case studies.
Nice programme, day 4 and 5 were very useful! A lot of tools to be implemented in daily work life!
I'm building a new team in my company, so I have to look at different aspects of managing teams and implementing changes. Really enjoyed the financial skills module and meeting different types of people!
Webinar 1: The effect of the contract on performance
Common sponsor concerns about partner performance, things that make people perform at their best, practical tips on getting it right
Webinar 2: A process for managing change
The 8 step approach to change, guides in managing change, example of process in action